The CBSE Class 12 Biotechnology syllabus for the 2026-27 academic year remains same as the previous year. It outlines the required chapters and subjects, assessment criteria, project work guidelines, ...

The ISC Board has made class 12th syllabus available for the academic year 2026-27. In this article we have explained the ...

Medical admissions through the NEET UG may no longer depend solely on entrance examination scores, with a government-appointed committee reportedly proposing 50 per cent weightage for Class ...

A common misconception in developing countries is that the world’s top-ranked universities focus primarily on Information ...

Board Marks May Account for 50 percent in NEET, JEE Admissions: ReportMedical admissions through the NEET UG may no longer depend solely on ...

An archive of the greatest moments, legendary players, and historic triumphs in World Cup history. QS I-GAUGE has launched an AI Adoption Survey for Educators, to assess educators’ perceptions of AI, ...

Banaras Hindu University (BHU) has commenced the admission process for the MSc Life Sciences program for the 2026-27 academic ...

HT SyndicationNew Delhi [India], June 15: A study conducted by FindMyCollege, covering more than 1 lakh active IT jobs in the current market, finds the pay ladder starting at a median of ₹2.6 LPA ...

Kota, Jun 21 (PTI) Candidates who appeared for the NEET-UG re-exam on Sunday reported that the paper was comparatively tougher than the previous exam, with Physics emerging as the most challenging sec ...

Education ; Two years in, the primary care / family medicine specialisation track is building real momentum. Two years ago, the Faculty of Medicine made a pedagogical wager: to im ...

Welcome to Fierce Biotech’s fifth annual layoff tracker, a resource designed to keep pace with the sector’s steady stream of workforce reductions. In 2025, industry layoffs continued to rise year over ...

Biotech investors are far more selective than they were during the pandemic-era boom, JPMorgan's top EMEA healthcare investment bankers told CNBC. Many biotech companies are now pursuing a dual-track ...